Homoharringtonine is a transdermal granular permeation enhancer.
Permeation enhancer
Stratum granulosum
Tight junction
Transdermal absorption
Journal
Biochemical and biophysical research communications
ISSN: 1090-2104
Titre abrégé: Biochem Biophys Res Commun
Pays: United States
ID NLM: 0372516
Informations de publication
Date de publication:
06 08 2022
06 08 2022
Historique:
received:
05
04
2022
revised:
12
04
2022
accepted:
14
04
2022
pubmed:
10
6
2022
medline:
18
6
2022
entrez:
9
6
2022
Statut:
ppublish
Résumé
Although modulation of claudin-1-based tight junction (TJ) in stratum granulosum is an option for transdermal absorption of drugs, granular permeation enhancers have never been developed. We previously found that homoharringtonine (HHT), a natural alkanoid, weakened intestinal epithelial barrier with changing expression and cellular localization of TJ components such as claudin-1 and claudin-4. In the present study, we investigated whether HHT is an epidermal granular permeation enhancer. Treatment of normal human epidermal keratinocytes (NHEK) cells with HHT decreased claudin-1 and claudin-4 but not zonula occludens-1 and E-cadherin. HHT lowered TJ-integrity in NHEK cells, accompanied by permeation-enhancement of dextran (4 kDa) in a dose-dependent manner. Transdermal treatment of mice with HHT weakened epidermal barrier. HHT treatment enhanced transdermal absorption of dextran with a molecular mass of up to 10 kDa. Together, HHT may be a transdermal absorption enhancer.
Identifiants
pubmed: 35679696
pii: S0006-291X(22)00596-4
doi: 10.1016/j.bbrc.2022.04.067
pii:
doi:
Substances chimiques
Claudin-1
0
Claudin-4
0
Dextrans
0
Homoharringtonine
6FG8041S5B
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
140-144Informations de copyright
Copyright © 2022. Published by Elsevier Inc.
Déclaration de conflit d'intérêts
Declaration of competing interest The authors have no conflicts of interest to declare.